Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., Greve, B., Woltering, F., Bozorg, A., Gayfieva, M., Kaminski, H. J. & MG0003 study team (2023).
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
The Lancet Neurology,
22(5), 383-394.
https://doi.org/10.1016/S1474-4422(23)00077-7Al-Hakem, H., Doets, A. Y., Stino, A. M., Zivkovic, S. A.
, Andersen, H., Willison, H. J., Cornblath, D. R., Gorson, K. C., Islam, Z., Mohammad, Q. D., Sindrup, S. H., Kusunoki, S., Davidson, A., Casasnovas, C., Bateman, K., Miller, J. A. L., Van Den Berg, B., Verboon, C., Roodbol, J. ... Jacobs, B. C. (2023).
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Neurology,
100(23), E2386-E2397.
https://doi.org/10.1212/WNL.0000000000207282
Hansen, P. N., Mohammed, A. A.
, Markvardsen, L. K., Andersen, H., Tankisi, H., Sindrup, S. H. & Krøigård, T. (2023).
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Journal of the Peripheral Nervous System,
28(3), 425-435.
https://doi.org/10.1111/jns.12563
Bril, V., Hadden, R. D. M., Brannagan, T. H., Bar, M., Chroni, E., Rejdak, K., Rivero, A.
, Andersen, H., Latov, N., Levine, T., Pasnoor, M., Sacconi, S., Souayah, N., Anderson-Smits, C., Duff, K., Greco, E., Hasan, S., Li, Z., Yel, L. & Ay, H. (2023).
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial.
Journal of the Peripheral Nervous System,
28(3), 436-449.
https://doi.org/10.1111/jns.12573Hu, X., Buhl, C. S., Sjogaard, M. B., Schousboe, K., Mizrak, H. I., Kufaishi, H., Hansen, C. S., Yderstræde, K. B.
, Jensen, T. S., Nyengaard, J. R. & Karlsson, P. (2023).
Structural Changes of Cutaneous Immune Cells in Patients With Type 1 Diabetes and Their Relationship With Diabetic Polyneuropathy.
Neurology: Neuroimmunology & Neuroinflammation,
10(5), Article e200144.
https://doi.org/10.1212/NXI.0000000000200144
Jensen, M., Sehner, S., Cheng, B., Schlemm, E., Quandt, F., Barow, E., Wegscheider, K., Boutitie, F., Ebinger, M., Endres, M., Fiebach, J. B., Thijs, V., Lemmens, R., Muir, K. W., Nighoghossian, N., Pedraza, S.
, Simonsen, C. Z., Thomalla, G. & Gerloff, C. (2023).
Patient-Reported Quality of Life after Intravenous Alteplase for Stroke in the WAKE-UP Trial.
Neurology,
100(2), E154-E162.
https://doi.org/10.1212/WNL.0000000000201375Barow, E., Pinnschmidt, H., Boutitie, F., Königsberg, A., Ebinger, M., Endres, M., Fiebach, J. B., Fiehler, J., Thijs, V., Lemmens, R., Muir, K. W., Nighoghossian, N., Pedraza, S.
, Simonsen, C. Z., Gerloff, C., Thomalla, G. & Cheng, B. (2020).
Symptoms and probabilistic anatomical mapping of lacunar infarcts.
Neurological Research and Practice,
2(1), Article 21.
https://doi.org/10.1186/s42466-020-00068-y